Ning Xiao1, Dan Zhu2, Shuiyuan Xiao3. 1. Department of Social Medicine and Health Management, School of Public Health, Central South University, Changsha 410078; Department of Nursing, PLA 169 Hospital, Hengyang 421002, Hunan Province, China. 2. Department of Nursing, PLA 169 Hospital, Hengyang 421002, Hunan Province, China. 3. Department of Social Medicine and Health Management, School of Public Health, Central South University, Changsha 410078, China.
Abstract
PURPOSE: Numerous studies have confirmed that brain tumor patients and their family members frequently exhibit negative emotional reactions, such as anxiety and depression, during diagnosis and treatment of the disease. Family members experience increasing pressure as the year of survival of patient progress. The aim of this study was to investigate the effects of the continued psychological care (CPC) toward the brain tumor patients and their family members' emotions. SUBJECTS AND METHODS: The asynchronous clinical control trial was performed, and 162 brain tumor patients and their family members were divided into the control group and the intervention group. The control group was only performed the telephone follow-up toward the patients. Beside this way, the intervention group was performed the CPC toward the patients and their family member. The self-rating anxiety scale (SAS) and the self-rating depression scale (SDS) were used to measure the negative emotions of the patients and their family members, and the patients' treatment compliance and the incidence of seizures were compared. RESULTS: The SAS and SDS scores of the intervention group on the 14 days, 28 days and 3 months of the CPC were significantly lower than the control group (P < 0.05); the SAS and SDS scores of the intervention group after the intervention were significantly lower than those at the discharging (P < 0.05), the treatment compliance of the intervention group was significantly higher than the control group (P < 0.05), and the seizure incidence of the intervention group was significantly lower than the control group (P < 0.05). CONCLUSION: The CPC could effectively reduce the anxiety and depression among the brain tumor patients and their family members.
PURPOSE: Numerous studies have confirmed that brain tumor patients and their family members frequently exhibit negative emotional reactions, such as anxiety and depression, during diagnosis and treatment of the disease. Family members experience increasing pressure as the year of survival of patient progress. The aim of this study was to investigate the effects of the continued psychological care (CPC) toward the brain tumor patients and their family members' emotions. SUBJECTS AND METHODS: The asynchronous clinical control trial was performed, and 162 brain tumor patients and their family members were divided into the control group and the intervention group. The control group was only performed the telephone follow-up toward the patients. Beside this way, the intervention group was performed the CPC toward the patients and their family member. The self-rating anxiety scale (SAS) and the self-rating depression scale (SDS) were used to measure the negative emotions of the patients and their family members, and the patients' treatment compliance and the incidence of seizures were compared. RESULTS: The SAS and SDS scores of the intervention group on the 14 days, 28 days and 3 months of the CPC were significantly lower than the control group (P < 0.05); the SAS and SDS scores of the intervention group after the intervention were significantly lower than those at the discharging (P < 0.05), the treatment compliance of the intervention group was significantly higher than the control group (P < 0.05), and the seizure incidence of the intervention group was significantly lower than the control group (P < 0.05). CONCLUSION: The CPC could effectively reduce the anxiety and depression among the brain tumor patients and their family members.
Entities:
Keywords:
Brain tumor; continued care; continued psychological care; patient's family members; patients
Authors: Quirien Oort; Hanneke Zwinkels; Johan A F Koekkoek; Maaike J Vos; Jaap C Reijneveld; Martin J B Taphoorn; Linda Dirven Journal: Psychooncology Date: 2022-01-28 Impact factor: 3.955
Authors: Tamara Ownsworth; Katarzyna Lion; Ursula M Sansom-Daly; Kerryn Pike; Eng-Siew Koh; Georgia K B Halkett; Mark B Pinkham; Raymond J Chan; Haryana M Dhillon Journal: Psychooncology Date: 2022-04-02 Impact factor: 3.955